AFX 2721

A lead drug candidate from a novel series of potent anti-inflammatory small molecules that inhibit the activity of TSLP, a key pro-inflammatory cytokine. TSLP plays a central role in the initiation of many atopic diseases and has been shown to be over-expressed by keratinocytes of patients with atopic dermatitis.